Autotelic Bio appointed Hyungbae Kwon as the Head of Strategic Planning Division in December 2023. 

After obtaining a certificate of KICPA (Korea Institute of Certified Public Accountant) in 2004, Director Kwon conducted audit at accounting firms such as Samjong KPMG for more than 10 years. He also oversaw tasks as a CFO in bio companies at Peptron and Syntekabio. His tasks included IPO (Initial Public Offering), IR/PR, accounting, funding, and disclosure, etc. 

Director Kwon's experience of IPO in bio companies and as an accountant will be a great asset for successfully pursuing Autotelic Bio's IPO in the future.  

Director Kwon will lead the Series C investment funding which is planned for next year and IPO while taking charge of Autotelic Bio's business strategies.